Загрузка...
A National Approach to Reimbursement Decision-Making on Drugs for Rare Diseases in Canada? Insights from Across the Ponds
INTRODUCTION: Regardless of the type of health system or payer, coverage decisions on drugs for rare diseases (DRDs) are challenging. While these drugs typically represent the only active treatment option for a progressive and/or life-threatening condition, evidence of clinical benefit is often limi...
Сохранить в:
| Опубликовано в: : | Healthc Policy |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Longwoods Publishing
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4748348/ https://ncbi.nlm.nih.gov/pubmed/26142357 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|